It has been reported that ANXA2 is more expressed in African American triple negative breast cancer (TNBC) patients compared to Caucasian TNBC patients, and high expression of ANXA2 is associated with worse survival [51]. The gene discussed is ANXA2; the disease is triple-negative breast carcinoma.